GeneDx Holdings Corp.
Stock Forecast, Prediction & Price Target
GeneDx Holdings Corp. (WGS) stock Price Target by analysts
$70
Potential downside: -43.76%
GeneDx Holdings Corp. price prediction
What is GeneDx Holdings Corp. stock analysts` prediction?
GeneDx Holdings Corp. stock forecast: Based on 1 Wall Street analysts` predicted price targets for GeneDx Holdings Corp. in the last 3 months, the avarage price target is $70, with a high forecast of $NaN. The average price target represents a -43.76% change from the last price of $124.47.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
GeneDx Holdings Corp. stock Price Target by analysts
Full breakdown of analysts given GeneDx Holdings Corp. price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Bill Bonello Craig-Hallum | 0% 0/2 | 11 months ago | $70 -43.76% downside | $58 | TheFly | Previous targets (1) |
Brandon Couillard Wells Fargo | 0% 0/1 | about 1 year ago | $34 -72.68% downside | $35.35 | TheFly | Previous targets (0) |
Mark Massaro BTIG | 33.33% 1/3 | about 1 year ago | $45 -63.84% downside | $30.13 | StreetInsider | Previous targets (2) |
Bill Bonello Craig-Hallum | 0% 0/2 | about 1 year ago | $43 -65.45% downside | $29.81 | TheFly | Previous targets (1) |
Mark Massaro BTIG | 33.33% 1/3 | over 1 year ago | $35 -71.88% downside | $26.19 | StreetInsider | Previous targets (2) |
Tycho Peterson Jefferies | 0% 0/1 | over 1 year ago | $21 -83.12% downside | $19.61 | TheFly | Previous targets (0) |
Mark Massaro BTIG | 33.33% 1/3 | over 1 year ago | $19 -84.73% downside | $11 | StreetInsider | Previous targets (2) |
GeneDx Holdings Corp. Financial Estimates
GeneDx Holdings Corp. Revenue Estimates
GeneDx Holdings Corp. EBITDA Estimates
GeneDx Holdings Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $212.19M N/A | $234.69M 10.60% | $202.56M -13.68% | Avg: $276.29M Low: $273.94M High: $280.65M avg. 36.39% | Avg: $327.05M Low: $324.28M High: $332.22M avg. 18.37% | ||
Net Income
% change YoY
| $-245.39M N/A | $-548.98M -123.71% | $-175.76M 67.98% | Avg: $-46.8M Low: $-38.95M High: $-37.74M avg. 73.37% | Avg: $16.89M Low: $16.71M High: $17.24M avg. 136.10% | ||
EBITDA
% change YoY
| $-424.34M N/A | $-395.6M 6.77% | $-136.46M 65.50% | Avg: $-206.98M Low: $-210.25M High: $-205.23M avg. -51.68% | Avg: $-245.02M Low: $-248.89M High: $-242.94M avg. -18.37% | ||
EPS
% change YoY
| -$74.93 N/A | -$53.63 28.42% | -$7.23 86.51% | Avg: -$1.57 Low: -$1.6 High: -$1.55 avg. 78.28% | Avg: $0.7 Low: $0.69 High: $0.71 avg. 144.26% | ||
Operating Expenses
% change YoY
| $429.54M N/A | $430.75M 0.28% | $224.28M -47.93% | Avg: $277.69M Low: $275.33M High: $282.07M avg. 23.81% | Avg: $328.71M Low: $325.92M High: $333.90M avg. 18.37% | ||
FAQ
What is GeneDx Holdings Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 104.73% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -38.95M, average is -46.8M and high is -37.74M.
What is GeneDx Holdings Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 27.38% in 2025-2026.
We have gathered data from 3 analysts. Their low revenue estimate is $273.94M, average is $276.29M and high is $280.65M.
What is GeneDx Holdings Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 111.27% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.6, average is -$1.57 and high is $-1.55.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering GeneDx Holdings Corp. stock. The most successful analyst is Bill Bonello.